JPRN-UMIN000012518已完成未知
Study of efficacy and tolerability of combination therapy with low-volume polyethylene glycol (Moviprep), sodium picosulfate hydrate (pursennid), mosapride citrate hydrate (gasmotin) on bowel preparation. - Study of efficacy and tolerability of combination therapy with low-volume polyethylene glycol (Moviprep), sodium picosulfate hydrate (pursennid), mosapride citrate hydrate (gasmotin) on bowel preparation.
Department of Gastroenterology, Juntendo University School of Medicine0 个研究点目标入组 50 人开始时间: 2013年12月9日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 64years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who has obstruction and/or suspicious obstruction of gastrointestinal tract 2.Patients who has intestinal perforation 3.Patients who has delayed exhaust in stomach 4.Patients with toxic megacolon. 5. Patients 65 years of age or older 6. Patients with aphasia
研究者
相似试验
已完成
2 期
Study of efficacy and tolerability of combination therapy with palonosetron and dexamethasone for the prevention of chemotherapy-induced nausea and vomiting in patients with cervical cancer.Cervical cancerJPRN-UMIN000004962Kyoto University Graduate School of Medicine40
尚未招募
4 期
A study to assess the effectiveness and safety of Combination of Omega-3 Fatty Acids and Vitamin E versus Combined Oral Contraceptive Pills in Polycystic Ovarian SyndromeCTRI/2024/04/066435Pandit B. D. Sharma UHS Rohtak
尚未招募
Unknown
Comparison of effectiveness of Ropivacaine and Bupivacaine for peribulbar anaesthesia in cataract surgeryCTRI/2024/08/071980Dr Rohini Kanagarajan
已完成
不适用
A comparative study of the efficacy of combination therapy with oral omeprazole and low dose of systemic meglumine antimoniate versus the standard dose of systemic meglumine antimoniate in the treatment of cutaneous leishmaniasisCutaneous leishmaniasisSkin and Connective Tissue DiseasesISRCTN32701387Skin Diseases and Leishmaniasis Research Center (SDLRC) (Iran)150
已完成
不适用
Investigation on efficacy and safety of combination treatment with imidafenacin and mirabegron in patients with overactive bladder.overactive bladderJPRN-UMIN000016236Clinical Research Support Center Kyushu30